Você procurou por: bil malti it tabib żar il pazjent (Maltês - Inglês)

it-tabib jista’ jwaqqaf il-kura b’libertek jekk il-pazjent jitlef wisq piż.
the doctor may stop treatment with libertek if the patient loses too much weight.

it-tabib jista’ jwaqqaf it-trattament b’daliresp jekk il-pazjent jitlef wisq piż.
the doctor may stop treatment with daliresp if the patient loses too much weight.

it-tabib jista’ jiddeċiedi li jwaqqaf il-kura jekk il-pazjent jiżviluppa ċerti effetti sekondarji.
the doctor may decide to interrupt or stop treatment if the patient develops certain side effects.

isem il-pazjent: isem it-tabib:
name patient: name doctor:

it-tabib jista' jinterrompi jew iwaqqaf il-kura jew inaqqas id-doża, jekk il-pazjent jiżviluppa ċerti effetti sekondarji serji.
the doctor may interrupt or stop treatment, or reduce the dose, if the patient develops certain serious side effects.

hekk kif ikun qed jikber il-pazjent, it-tabib jibdel id-doża.
as the patient grows the doctor will adjust the dose.

jekk ikun hemm doża eċċessiva, il-pressjoni ġol-għajnejn għandha tiġi mmonitorjata u kkurata, kif jidhirlu xieraq it-tabib li jkun qed jieħu ħsieb il-pazjent.
if an overdose occurs, intraocular pressure should be monitored and treated, if deemed necessary by the attending physician.

għalhekk, qabel ma jmur għand it-tabib sabiex jibbenefika mis-servizzi tal-kura li jkunu mħallsa biss minn terzi, il-pazjent għandu jinforma ruħu jekk:
thus, before going to the doctor for care services under the direct billing system, the patient should ascertain whether:

il-kura tista’ tiġi posposta skont kif jidhirlu li hemm bżonn it-tabib li qed jikkura, jekk il-pazjent ikollu kumplikazzjonijiet assoċjati ma’ majelosoppressjoni, bħal dawk deskritti hawn taħt:
treatment may be delayed at the discretion of the treating physician, if the patient experiences myelosuppression-associated complications, such as those described below:

jekk il-pazjent ma jkunx jista' jittollera doża miżjuda, it-tabib jista' jkollu jnaqqasha.
if the patient cannot tolerate an increased dose, the doctor may have to reduce it.

wara taħriġ, il- pazjent jew min jipprovdi kura jista’ jagħti l-infużjoni mid-dar, jekk it-tabib tal-pazjent ikun jemmen li dan ikun xieraq.
after training, the patient or carer can give the infusion at home, if their doctor believes it is appropriate.

isem il-pazjent: isem it-tabib: in-numru tat-telefon tat-tabib:
patient’s name: doctor’s name: doctor’s phone:

jekk il-pazjent jesperjenza bidla sinifikanti fis-sinjali vitali, it-tabib għandu jevalwa l-istatus tal-pazjent u jkompli jissorvelja s-sinjali vitali; dawn il-pazjenti għandhom ikunu sorveljati waqt trattamenti sussegwenti.
if the patient experiences a significant change in vital signs, the physician should evaluate the status of the patient and continue to monitor vital signs; these patients should be monitored during subsequent treatments.